Skip to main content
Drew Weissman, MD, Allergy & Immunology, Philadelphia, PA

Drew Weissman MD


Associate Professor, Medicine, Perelman School of Medicine

Join to View Full Profile
  • 3900 Woodland AvePhiladelphia, PA 19104

  • Phone+1 215-823-5800

Dr. Weissman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1990 - 1993
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1987 - 1990
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1987

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1997 - 2026
  • MD State Medical License
    MD State Medical License 1990 - 1997

Publications & Presentations

PubMed

Press Mentions

  • Why Is Philadelphia Called the Cellicon Valley?
    Why Is Philadelphia Called the Cellicon Valley?April 1st, 2025
  • New Technology Is Poised to Bring Gene Therapy to Common Chronic Diseases
    New Technology Is Poised to Bring Gene Therapy to Common Chronic DiseasesMarch 25th, 2025
  • Remembrance and Resilience at Penn Medicine Five Years After COVID-19
    Remembrance and Resilience at Penn Medicine Five Years After COVID-19March 4th, 2025
  • Join now to see all

Grant Support

  • Cardiac delivery of RNA to treat contractile disorderUNIVERSITY OF PENNSYLVANIA2024–2028
  • Cardiac delivery of RNA to treat contractile disorderUNIVERSITY OF PENNSYLVANIA2024–2028
  • Cardiac delivery of RNA to treat contractile disorderUNIVERSITY OF PENNSYLVANIA2024–2028
  • mVACS--mRNA Vaccines for C. difficile SuppressionUNIVERSITY OF PENNSYLVANIA2023–2028
  • Vascular Targeting of Nanocarriers for RNAUNIVERSITY OF PENNSYLVANIA2021–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: